Action Kaleido Biosciences (EM) - KLDO

Kaleido Biosciences Inc (EM) (KLDO) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,0001

( - )

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

Volume moyen (3 m)

US$ 2 986

Volume financier

0,00 Fourchette du Jour 0,00

0,000001 Plage de 52 semaines 0,35

Cap du marché

4,262k

Valeur d'Entreprise

Clôture Veille

0,0001

Ouverture

Dernière Transaction

Dernière heure de transaction

VWAP

Chiffre d'affairess (LTM)

1,1M

Bénéfice net (LTM)

-90,29M

Actions en circulation

42 622 559

Flottant (%)

Détention Institutionnelle (%)

0,01%

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

Ratio Cours/Ventes (P/S)

Bénéfice par action (BPA)

-2,16

Bêta

37,01

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-1... Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of ulcerative colitis, psoriasis, atopic immune disease, chronic obstructive pulmonary disease pathogens, and immuno-oncology. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Show more

Secteur

Healthcare

Industrie

Biotechnology & Life Sciences

Site Web

kaleido.com

Siège social

Lexington, United States

Fondé

2026

Kaleido Biosciences Inc (EM) est coté dans le secteur Healthcare de la OTC Markets avec le ticker KLDO. Le dernier cours de clôture d'Kaleido Biosciences (EM) était de US$0,00. Au cours de la dernière année, les actions de Kaleido Biosciences (EM) ont été négociées dans une fourchette de prix de US$ 0,000001 à US$ 0,35.

Kaleido Biosciences (EM) compte actuellement 42 622 559 actions en circulation. La capitalisation boursière d'Kaleido Biosciences (EM) est de US$4 262,26 . Kaleido Biosciences (EM) a un ratio cours/bénéfice (ratio PE) de 0.

Revoked Security

Tue, Jun 11, 2013 12:00 - Kaleidoscope Venture Capital, Inc. (KLDO: Grey Market) - Revoked Security - Effective Tue, Jun 11, 2013, KLDO is...

Venue Change

Fri, May 24, 2013 12:00 - Kaleidoscope Venture Capital, Inc. (KLDO: Grey Market) - Venue Change - The symbol, KLDO, no longer trades on OTC Link...

Suspended Security

Wed, May 22, 2013 12:00 - Kaleidoscope Venture Capital, Inc. (KLDO: OTC Link) - Suspended Security - Effective Wed, May 22, 2013, KLDO is...

Kaleidoscope Digital Media Systems, DBA of Kaleidoscope Venture Capital Inc., Announces the Creation of Kaleidoscope Internet...

SEATTLE, WA -- (Marketwire) -- 01/25/12 -- Kaleidoscope Venture Capital Inc. ("Kaleidoscope" or the "Company") (PINKSHEETS: KLDO), today...

Kaleidoscope Venture Capital, Inc. Announces the Creation of KALEIDOSCOPE CONNECT

SEATTLE, WA -- (Marketwire) -- 01/23/12 -- Kaleidoscope Venture Capital, Inc. ("Kaleidoscope" or the "Company") (PINKSHEETS: KLDO), under its DBA...

Correction: QED Connect, Inc. Signs Agreement to Acquire 75% of Kaleidoscope Venture Capital, Inc.

Correction: QED Connect, Inc. Signs Agreement to Acquire 75% of Kaleidoscope Venture Capital, Inc. PR Newswire MANCHESTER, N.H., Oct. 7, 2011...

QED Connect, Inc., Signs Letter of Intent to Acquire 75% of Kaleidoscope Venture Capital, Inc.

QED Connect, Inc., Signs Letter of Intent to Acquire 75% of Kaleidoscope Venture Capital, Inc. PR Newswire MANCHESTER, N.H., Oct. 7, 2011...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.0001	0.001	1.0E-6	1584	9.583E-5	CS
4	0	0	0.0001	0.20005	1.0E-6	3527	9.881E-5	CS
12	0	0	0.0001	0.20005	1.0E-6	2335	0.00011846	CS
26	0	0	0.0001	0.20005	1.0E-6	2219	0.00010943	CS
52	0	0	0.0001	0.35	1.0E-6	20048	0.00039107	CS
156	9.9E-5	9900	1.0E-6	0.35	1.0E-6	10071	0.00033815	CS
260	-0.0018	-94.7368421053	0.0019	0.35	1.0E-6	81304	0.06053205	CS

KLDO - Frequently Asked Questions (FAQ)

What is the current Kaleido Biosciences Inc (EM) share price?

The current share price of Kaleido Biosciences Inc (EM) is US$ 0,0001

How many Kaleido Biosciences Inc (EM) shares are in issue?

Kaleido Biosciences Inc (EM) has 42 622 559 shares in issue

What is the market cap of Kaleido Biosciences Inc (EM)?

The market capitalisation of Kaleido Biosciences Inc (EM) is USD 4,26k

What is the 1 year trading range for Kaleido Biosciences Inc (EM) share price?

Kaleido Biosciences Inc (EM) has traded in the range of US$ 0,000001 to US$ 0,35 during the past year

What is the cash to sales ratio of Kaleido Biosciences Inc (EM)?

The cash to sales ratio of Kaleido Biosciences Inc (EM) is 0

What is the registered address of Kaleido Biosciences Inc (EM)?

The registered address for Kaleido Biosciences Inc (EM) is 65 Hayden Avenue, Lexington, Massachusetts, 02421

What is the Kaleido Biosciences Inc (EM) website address?

The website address for Kaleido Biosciences Inc (EM) is kaleido.com

Which industry sector does Kaleido Biosciences Inc (EM) operate in?

Kaleido Biosciences Inc (EM) operates in the Biotechnology & Life Sciences sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Kaleido Biosciences Inc (EM) (KLDO)

Kaleido Biosciences Inc (EM) (KLDO) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Kaleido Biosciences Inc (EM)